# LUCIER PHARMACEUTICALS INC: Diagnostic and Therapeutic Potential of LU-1001 for Coronary Microvascular Dysfunction

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | LUCIER PHARMACEUTICALS INC |
| Location | CYPRESS, TX |
| Project | Diagnostic and Therapeutic Potential of LU-1001 for Coronary Microvascular Dysfunction |
| Project number | 1R41HL184579-01A1 |
| Mechanism | R41 |
| Institute | National Heart Lung and Blood Institute |
| Award | $606,311 |
| Awarded | 2026-09-11 |
| Project period | 2026-09-15 to 2027-08-31 |
| UEI | CGF6SZLMNUM7 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11409376). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.